Dep of Anesthesia and Intensive Care, Rikshospitalet-Radiumhospitalet Medical Center
Oslo, 0027, Norway
NCT Number: NCT00730054
The hypothesis is that systemic remifentanil and Clonidine act in a synergistic manner to relief acute main in an experimental human pain model. Of interest is also the effect of the combination on respiration, sedation and cognitive behavior.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Phase 1 / Phase 2
Oslo, 0027, Norway
To examine the possible synergistic effects og systemic remifentanil and clonidine. Its effects on respiration, cognitive function and sedation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
iv Remifentanil+ iv clonidine
Other names: Ultiva, Catapressan
Time frame: Experimental
Time frame: Experimental
Time frame: experimental
Time frame: Experimental
Time frame: Experimental
Oslo University Hospital
Other
Acronym: Remiclon
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735884
Acute Pain, Femoral Fractures
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07335159
Acute Pain, Agnosia
Tallahassee, Florida, United States
View Trial DetailsNCT07500454
Acute Pain, Neurologic Manifestations
Mexico City, Mexico
View Trial DetailsNCT05229055
Acute Pain, Neurologic Manifestations
Monastir, Tunisia
View Trial Details